Cover Image

SomaGenics Inc.:產品平台分析

SomaGenics Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 311911
出版日期 內容資訊 英文 20 Pages
Back to Top
SomaGenics Inc.:產品平台分析 SomaGenics Inc. - Product Pipeline Review - 2015
出版日期: 2015年07月15日 內容資訊: 英文 20 Pages

本報告提供SomaGenics Inc.的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台的分析與最新趨勢等資訊。

SomaGenics Inc.的基本資料

SomaGenics Inc.概要

  • 主要資訊
  • 企業資料

SomaGenics Inc.:R&D概要

  • 主要的治療範圍

SomaGenics Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

SomaGenics Inc.:開發中產品概況

  • 初期階段有的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

SomaGenics Inc.:藥物簡介

  • C型肝炎RNAi寡核甘酸
  • D型肝炎RNAi寡核甘酸
  • 創傷治療RNAi寡核甘酸

SomaGenics Inc.:開發平台分析

  • 各分子類型

SomaGenics Inc.:最近的開發平台趨勢

SomaGenics Inc.:暫停中的計劃

SomaGenics Inc.:總公司和子公司的所在地



Product Code: GMDHC07325CDB


Global Markets Direct's, 'SomaGenics Inc. - Product Pipeline Review - 2015', provides an overview of the SomaGenics Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of SomaGenics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of SomaGenics Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of SomaGenics Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the SomaGenics Inc.'s pipeline products

Reasons to buy

  • Evaluate SomaGenics Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of SomaGenics Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the SomaGenics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of SomaGenics Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of SomaGenics Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of SomaGenics Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • SomaGenics Inc. Snapshot
    • SomaGenics Inc. Overview
    • Key Information
    • Key Facts
  • SomaGenics Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • SomaGenics Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • SomaGenics Inc. - Pipeline Products Glance
    • SomaGenics Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • SomaGenics Inc. - Drug Profiles
    • RNAi Oligonucleotide for Hepatitis C
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RNAi Oligonucleotide for Hepatitis D
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RNAi Oligonucleotide for Wound Healing
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • SomaGenics Inc. - Pipeline Analysis
    • SomaGenics Inc. - Pipeline Products by Molecule Type
  • SomaGenics Inc. - Recent Pipeline Updates
  • SomaGenics Inc. - Dormant Projects
  • SomaGenics Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • SomaGenics Inc., Key Information
  • SomaGenics Inc., Key Facts
  • SomaGenics Inc. - Pipeline by Indication, 2015
  • SomaGenics Inc. - Pipeline by Stage of Development, 2015
  • SomaGenics Inc. - Monotherapy Products in Pipeline, 2015
  • SomaGenics Inc. - Preclinical, 2015
  • SomaGenics Inc. - Discovery, 2015
  • SomaGenics Inc. - Pipeline by Molecule Type, 2015
  • SomaGenics Inc. - Recent Pipeline Updates, 2015
  • SomaGenics Inc. - Dormant Developmental Projects,2015

List of Figures

  • SomaGenics Inc. - Pipeline by Top 10 Indication, 2015
  • SomaGenics Inc. - Pipeline by Stage of Development, 2015
  • SomaGenics Inc. - Monotherapy Products in Pipeline, 2015
  • SomaGenics Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top